1083 related articles for article (PubMed ID: 29981289)
41. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
[TBL] [Abstract][Full Text] [Related]
42. Up-regulation of long non-coding RNA HOXA-AS2 in non-small cell lung cancer is associated with worse survival outcome.
Li Y; Jiang H
Int J Clin Exp Pathol; 2017; 10(9):9690-9696. PubMed ID: 31966850
[TBL] [Abstract][Full Text] [Related]
43. LncRNA HOXA-AS2 regulates microglial polarization via recruitment of PRC2 and epigenetic modification of PGC-1α expression.
Yang X; Zhang Y; Chen Y; He X; Qian Y; Xu S; Gao C; Mo C; Chen S; Xiao Q
J Neuroinflammation; 2021 Sep; 18(1):197. PubMed ID: 34511122
[TBL] [Abstract][Full Text] [Related]
44. Long noncoding RNA GHET1 in human cancer.
Li J; Jiang X; Li Z; Huang L; Zhou Y; Liu Y; Cui Y
Clin Chim Acta; 2019 Jan; 488():111-115. PubMed ID: 30399371
[TBL] [Abstract][Full Text] [Related]
45. HOXA cluster antisense RNA 2 elevates KIAA1522 expression through microRNA-520d-3p and insulin like growth factor 2 mRNA binding protein 3 to promote the growth of vascular smooth muscle cells in thoracic aortic aneurysm.
Ou M; Chu Y; Zhang Q; Zhao H; Song Q
ESC Heart Fail; 2022 Oct; 9(5):2955-2966. PubMed ID: 35730141
[TBL] [Abstract][Full Text] [Related]
46. Long non-coding RNA HOXA-AS2 promotes the expression levels of hypoxia-inducible factor-1α and programmed death-ligand 1, and regulates nasopharyngeal carcinoma progression via miR-519.
Wang S; You H; Yu S
Oncol Lett; 2020 Nov; 20(5):245. PubMed ID: 32973958
[TBL] [Abstract][Full Text] [Related]
47. Research Progress on Long Non-Coding RNA and Radiotherapy.
Yao Z; Zhang Y; Xu D; Zhou X; Peng P; Pan Z; Xiao N; Yao J; Li Z
Med Sci Monit; 2019 Aug; 25():5757-5770. PubMed ID: 31375656
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA HOXD-AS1 in cancer.
Li L; Wang Y; Zhang X; Huang Q; Diao Y; Yin H; Liu H
Clin Chim Acta; 2018 Dec; 487():197-201. PubMed ID: 30290157
[TBL] [Abstract][Full Text] [Related]
49. Effects of Long Noncoding RNA HOXA-AS2 on the Proliferation and Migration of Gallbladder Cancer Cells.
Zhang P; Liu L; Zhang W; Fang J; Li G; Zhang L; Li J; Deng X; Ma J; Li K; Chen Z
J Oncol; 2022; 2022():6051512. PubMed ID: 36299503
[TBL] [Abstract][Full Text] [Related]
50. Long non-coding SNHG1 in cancer.
Thin KZ; Tu JC; Raveendran S
Clin Chim Acta; 2019 Jul; 494():38-47. PubMed ID: 30849309
[TBL] [Abstract][Full Text] [Related]
51. Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer.
Li Q; Dai Y; Wang F; Hou S
Neoplasma; 2016; 63(6):977-983. PubMed ID: 27596298
[TBL] [Abstract][Full Text] [Related]
52. The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.
Xu S; Wang P; You Z; Meng H; Mu G; Bai X; Zhang G; Zhang J; Pang D
Oncotarget; 2016 Apr; 7(15):20704-17. PubMed ID: 26980733
[TBL] [Abstract][Full Text] [Related]
53. LncRNA HOXA-AS2 positively regulates osteogenesis of mesenchymal stem cells through inactivating NF-κB signalling.
Zhu X; Yu J; Du J; Zhong G; Qiao L; Lin J
J Cell Mol Med; 2019 Feb; 23(2):1325-1332. PubMed ID: 30536618
[TBL] [Abstract][Full Text] [Related]
54. TUG1: a pivotal oncogenic long non-coding RNA of human cancers.
Li Z; Shen J; Chan MT; Wu WK
Cell Prolif; 2016 Aug; 49(4):471-5. PubMed ID: 27339553
[TBL] [Abstract][Full Text] [Related]
55. WDFY3-AS2: A Potential Prognostic Factor and Therapeutic Target Related to Cancer.
Mou J; Chen J; Wu Y; He Y; Zhou G; Yuan C
Curr Med Chem; 2023; 30(25):2814-2821. PubMed ID: 36093824
[TBL] [Abstract][Full Text] [Related]
56. LncRNA-DANCR: A valuable cancer related long non-coding RNA for human cancers.
Thin KZ; Liu X; Feng X; Raveendran S; Tu JC
Pathol Res Pract; 2018 Jun; 214(6):801-805. PubMed ID: 29728310
[TBL] [Abstract][Full Text] [Related]
57. CCAT1: an oncogenic long noncoding RNA in human cancers.
Guo X; Hua Y
J Cancer Res Clin Oncol; 2017 Apr; 143(4):555-562. PubMed ID: 27638771
[TBL] [Abstract][Full Text] [Related]
58. HOXA-AS2 may predict the prognosis of solid tumors among Chinese patients: A meta-analysis and bioinformatic analysis.
Wang Q; Zhang W; Deng C; Lin S; Zhou Y
Front Oncol; 2022; 12():1030825. PubMed ID: 36387249
[TBL] [Abstract][Full Text] [Related]
59. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.
Soltani R; Amini M; Mazaheri Moghaddam M; Jebelli A; Ahmadiyan S; Bidar N; Baradaran B; MotieGhader H; Asadi M; Mokhtarzadeh A
Mol Biol Rep; 2022 Jul; 49(7):6817-6826. PubMed ID: 34981339
[TBL] [Abstract][Full Text] [Related]
60. ZFAS1: A novel vital oncogenic lncRNA in multiple human cancers.
He A; He S; Li X; Zhou L
Cell Prolif; 2019 Jan; 52(1):e12513. PubMed ID: 30288832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
